- Shares of Mastercard Integrated (MA) gained 2.5% after the corporate reported second-quarter 2026 earnings of $5.04 per share, beating the Zacks Consensus Estimate of $4.77 per share.
- Bristol-Myers Squibb Firm’s (BMY) shares elevated 2.8% after the corporate reported second-quarter 2026 earnings of $2.04 per share, surpassing the Zacks Consensus Estimate of $1.59 per share.
- Shares of Altria Group, Inc. (MO) plunged 9.2% after the corporate reported second-quarter 2026 earnings of $1.48 per share, lacking the Zacks Consensus Estimate of $1.5 per share.
- Regeneron Prescription drugs, Inc.’s (REGN) shares jumped 6.2% after the corporate reported second-quarter 2026 earnings of $14.29 per share, outpacing the Zacks Consensus Estimate of $10 per share.
Zacks’ Analysis Chief Names “Inventory Most More likely to Double”
Our staff of consultants has simply launched the 5 shares with the best likelihood of gaining +100% or extra within the coming months. Of these 5, Director of Analysis Sheraz Mian highlights the one inventory set to climb highest.
This high choose is a little-known satellite-based communications agency. Area is projected to change into a trillion greenback trade, and this firm’s buyer base is rising quick. Analysts have forecasted a serious income breakout in 2025. After all, all our elite picks aren’t winners however this one might far surpass earlier Zacks’ Shares Set to Double like Hims & Hers Well being, which shot up +209%.
Free: See Our High Inventory And 4 Runners Up
Regeneron Prescription drugs, Inc. (REGN) : Free Inventory Evaluation Report
Mastercard Integrated (MA) : Free Inventory Evaluation Report
Bristol Myers Squibb Firm (BMY) : Free Inventory Evaluation Report
Altria Group, Inc. (MO) : Free Inventory Evaluation Report
This text initially revealed on Zacks Funding Analysis (zacks.com).
The views and opinions expressed herein are the views and opinions of the writer and don’t essentially replicate these of Nasdaq, Inc.
